COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Initiates Enrollment of the Second Last Cohort in U.S. Combination Treatment Study of Its Lung Cancer Drug Candidate L-DOS47
13/09/2018
RICHMOND HILL, Ontario, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson
13/09/2018
Small molecule lead drug candidate blocks a critical target for tumors and crosses the blood brain barrier; begins first brain cancer patient dosing in clinical trial at MD Anderson Cancer Center HOUSTON, Sept. 13, 2018 [...]
ProMIS Neurosciences Appoints James Kupiec, MD as Chief Medical Officer
13/09/2018
Dr. Kupiec to leverage neurodegenerative experience from prior senior positions at Pfizer and Sanofi-Synthelabo TORONTO and CAMBRIDGE, Mass., Sept. 13, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN; [...]
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018
13/09/2018
OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2018 Oxford, UK – 13 September 2018: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE: OXB), a leading gene and cell therapy group, [...]
Oxford BioMedica announces further capacity expansion with new facility
13/09/2018
Oxford BioMedica announces further capacity expansion with new facility Lentiviral vector bioprocessing market expected to grow to $800m by 2026 Oxford BioMedica adds fourth facility in Oxford allowing the Group to [...]
Scapa Healthcare Enters Agreement to Acquire Advanced Wound Dressing Facility in the UK
13/09/2018
Transaction to Expand Scapa Healthcare Advanced Wound Care Capabilities & Services WINDSOR, Conn., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin friendly turn- [...]
Breathtec Provides Nash Pharmaceuticals’ Plans for Next Year
13/09/2018
VANCOUVER, British Columbia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH ) (CNSX: BTH ) (FRANKFURT: BTI) (OTCQB: BTHCF ) (the “Company”) is pleased to provide details on Nash Pharmaceutical’s [...]
G1 Therapeutics Announces Appointment of Garry Nicholson to Board of Directors
13/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 13, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Garry Nicholson has been appointed to its board of directors [...]
Emblem launches Atmosphere, its first oral dose-metered spray
13/09/2018
Atmosphere provides patients with precise dosing and convenient delivery TORONTO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned [...]
Nightstar Appoints Strategic Biotechnology Executive Paula Cobb to its Board of Directors
13/09/2018
WALTHAM, Mass. and LONDON, United Kingdom, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, [...]
Sanofi to refocus two global business units
13/09/2018
Sanofi to refocus two global business units Appoints Dieter Weinand to lead new Primary Care business unit New China & Emerging Markets business to be led by Olivier Charmeil Stefan Oelrich will leave Sanofi to [...]
Sanofi recentre deux de ses entités commerciales globales
13/09/2018
Sanofi recentre deux de ses entités commerciales globales Nomination de Dieter Weinand à la tête de la nouvelle entité commerciale globale Soins Primaires La nouvelle entité commerciale globale Chine et Marchés [...]
Dermira Presents New Pediatric Efficacy and Safety Data for Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis at the European Academy of Dermatology and Venereology Congress
13/09/2018
Primary axillary hyperhidrosis is a medical condition that can occur in the pediatric population and is largely undertreated and under-diagnosed Post-hoc analysis of ARIDO long-term safety study demonstrated reduced [...]
JSC Olainfarm: the Council of the Company has been elected legally and works for the long-term interests of the company
13/09/2018
The new council of JSC Olainfarm has been elected legally, represents the interests of shareholders and works in the long-term interests of the company, implementing and developing the vision of development of Valērijs [...]
Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"
13/09/2018
PRESS RELEASE Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at the scientific conference "European Huntington's Disease Network (EHDN) plenary meeting 2018" Lund Sweden, [...]
HealthLynked Corp. Announces Partnership to Offer Discount Medical Supplies to its Members and Healthcare Providers
13/09/2018
NAPLES, Fla., Sept. 13, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced its partnership with MedOfficeDirect, LLC, an online retailer of discount medical supplies. MedOfficeDirect sells [...]
Solon Eiendom ASA – Primary insider notification
13/09/2018
(Oslo, Norway, September 12, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 10.000 shares in Solon Eiendom ASA at a price of NOK 29,0632. Following [...]
Shire plc : Rule 2.9 Announcement
13/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 September 2018 [...]
ERYTECH to Attend Upcoming Investor Conferences
13/09/2018
LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside [...]

Pages